The Effect of High Storage Temperature on the Stability and Efficacy of Lyophilized Tenecteplase.

Prehospital and Disaster Medicine
Emily HenkelAndrew Fenning

Abstract

Tenecteplase is a thrombolytic protein drug used by paramedics, emergency responders, and critical care medical personnel for the prehospital treatment of blood clotting diseases. Minimizing the time between symptom onset and the initiation of thrombolytic treatment is important for reducing mortality and improving patient outcomes. However, the structure of protein drug molecules makes them susceptible to physical and chemical degradation that could potentially result in considerable adverse effects. In locations that experience extreme temperatures, lyophilized tenecteplase transported in emergency service vehicles (ESVs) may be subjected to conditions that exceed the manufacturer's recommendations, particularly when access to the ambulance station is limited. This study evaluated the impact of heat exposure (based on temperatures experienced in an emergency vehicle during summer in a regional Australian city) on the stability and efficacy of lyophilized tenecteplase. Vials containing 50mg lyophilized tenecteplase were stored at 4.0°C (39.2°F), 35.5°C (95.9°F), or 44.9°C (112.8°F) for a continuous period of eight hours prior to reconstitution. Stability and efficacy were determined through assessment of: optical clarity and p...Continue Reading

References

Feb 1, 1989·Annals of Emergency Medicine·T D ValenzuelaJ B Clark
Sep 1, 1993·The American Journal of Emergency Medicine·R B JohansenP I Brown
Aug 19, 1999·The American Journal of Emergency Medicine·M D GottwaldB K Alldredge
Aug 25, 1999·Drug Development and Industrial Pharmacy·B Kommanaboyina, C T Rhodes
Nov 24, 1999·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·J R AllegraB MacKenzie
Feb 25, 2000·Thrombosis Research·M LópezC L Arocha-Piñango
Mar 24, 2000·The Journal of Emergency Medicine·W C DuBois
May 20, 2000·JAMA : the Journal of the American Medical Association·L J MorrisonD J Cook
Apr 12, 2003·Journal of Vascular and Interventional Radiology : JVIR·Charles P SembaThomas Patapoff
Jul 2, 2003·Emergency Medicine Journal : EMJ·A WakaiD Winter
Apr 6, 2004·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Mark A GillAngela Chandna
Mar 4, 2005·Journal of Thrombosis and Thrombolysis·Christoph MelzerMichael Laule
Nov 9, 2005·Vascular Pharmacology·Dev B BaruahS S Kadam
Dec 13, 2005·The American Journal of Emergency Medicine·Lawrence H BrownCalvin D Tran
Sep 14, 2006·Thrombosis Journal·Sweta PrasadHatim F Daginawala
Oct 10, 2006·The AAPS Journal·Amy S Rosenberg
Jun 7, 2008·The American Journal of Emergency Medicine·Dustin L GammonRoger Huckfeldt
Feb 4, 2010·Thrombosis and Haemostasis·M Böhm-WeigertD Peetz
Mar 19, 2011·Hemodialysis International·Yvonne K LentzXanthe Lam
Mar 24, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Julia Christina Kasper, Wolfgang Friess
Aug 20, 2011·JACC. Cardiovascular Interventions·Thao HuynhNicolas Danchin
Dec 2, 2011·Methods in Molecular Biology·Katherine L TuckerJonathan M Gibbins
Nov 15, 2012·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors·Jason T McMullanUNKNOWN Neurological Emergencies Treatment Trials investigators
May 29, 2013·Annals of Emergency Medicine·Sabrina De WinterJean-Bernard Gillet
Mar 25, 2014·Advances in Hematology·Abuzar ElnagerZulkifli Mustafa
Mar 27, 2016·Laboratory Medicine·Roger S RileyRichard A McPherson
Aug 31, 2016·International Journal of Medical Informatics·Yun Hee JoHyang Sook Kim
Jan 5, 2017·Drug Development and Industrial Pharmacy·Yanan CuiHua Guan
Dec 7, 2018·Lancet Neurology·Audrey M ThiebautBenoit D Roussel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.